sitagliptin/metformin hydrochloride teva 50 mg/1000 mg apvalkotās tabletes
teva gmbh, germany - sitagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/1000 mg
vildagliptin/metformin teva 50 mg/1000 mg apvalkotās tabletes
teva b.v., netherlands - vildagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/1000 mg
sitagliptin/metformin hydrochloride sandoz 50 mg/1000 mg apvalkotās tabletes
sandoz d.d., slovenia - sitagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/1000 mg
vildagliptin/metformin elvim 50 mg/1000 mg apvalkotās tabletes
elvim, sia, latvia - vildagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/1000 mg
vildagliptin/metformin sanoswiss 50 mg/1000 mg apvalkotās tabletes
sanoswiss uab, lithuania - vildagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/1000 mg
eucreas
novartis europharm limited - vildagliptin, metformīns hidrohlorīds - cukura diabēts, 2. tips - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - vildagliptin, metformīns hidrohlorīds - cukura diabēts, 2. tips - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 un 5. 1 pieejamo datu par dažādām kombinācijām).
zomarist
novartis europharm limited - vildagliptin, metformīns hidrohlorīds - cukura diabēts, 2. tips - cukura diabēts - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.
sitagliptin/metformin billev 50 mg/1000 mg apvalkotās tabletes
billev farmacija vzhod d.o.o., slovenia - sitagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/1000 mg
vildagliptin teva 50 mg tabletes
teva b.v., netherlands - vildagliptīns - tablete - 50 mg